Small molecule compound
Product Name
CAS Number
Specification
TP
DMF
Status
Imatinib Mesylate
220127-57-1
EP, In-house
√
Inavolisib
2060571-02-8
Q4 2025
Q2 2026
Ivacaftor
873054-44-5
Q3 2025
Q1 2026
Lactulose
4618-18-2
Q42025
Q1 2026
Lapatinib
231277-92-9
Q4 2025
Q2 2026
Latanoprost
130209-82-4
USP, EP
√
Lenvatinib Mesylate
857890-39-2
In-house
√
Lifitegrast
1025967-78-5
Q4 2025
Q2 2026
Limaprost
74397-12-9
Q4 2025
Q2 2026
Lorlatinib
1454846-35-5
Q3 2025
Q1 2026
Lotilaner
1369852-71-0
Q4 2025
Q2 2026
Lubiprostone
333963-40-9
In-house
√
Lumateperone Tosylate
1187020-80-9
In-house
Correct
Luseogliflozin Hydrate
898537-18-3
Q4 2025
Q2 2026
Macitentan
441798-33-0
In-house
√
Maralixibat chloride
228113-66-4
In-house
√
Miglitol
72432-03-2
JP, In-house
√
Mirogabalin Besylate
1138245-21-2
Q3 2025
Q1 2026
Nebivolol Hydrochloride
152520-56-4
EP, In-house
√
Nirogacestat hydrobromide
1962925-29-6
Q4 2025
Q2 2026